 SHELTON, CT ACCESSWIRE April 13, 2020 NanoViricides, Inc. NYSE American:NNVC the Company a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform the Company, states that its President, Dr. Anil R. Diwan was interviewed by broadcast journalist Christine Corrado of Proactive Investors, a leading, multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt, and London. The interview took place remotely, with Dr. Diwan and key staff members at the Companys Shelton, CT headquarters, on March 27, 2020. A video transcript of the interview published by Proactive Investors is now available at and on the Companys website at 